Menu
Online Investor Engagement Specialists
About Us
Why Choose IRM
Our Team
Our Approach
Our Partners
Our Products and Services
Product Catalogue
Terms and Conditions
IRM Careers
Investor Websites
About Investor Websites
Making the New Website Project Easier
Pricing
Optional Features
IRM Newsroom
About IRM Newsroom
Features and Benefits
Pricing
IRM Newsroom Special Features
IRM Events
About IRM Events
Features and Benefits
Promote Investor Events
Plan Your Next Events
Provide Event Details
Publish Your Events
Send Invitations and Reminders
Manage Registrations
Run Your Events
Follow Up Attendees
Analyse Results
Pricing
Annual Reports
About Annual Reports
Features and Benefits
Pricing
Prospectus
News + Insights
IR Insights
Client Stories
Contact
Contact Us
Email Alerts
Neuren Pharmaceuticals Limited
Company Description
Neuren (ASX: NEU) has two drugs in clinical development for multiple serious neurological disorders that emerge in early childhood, for which currently there are no approved drug therapies.
IRMatters Case Study
alt
Project Location
Project Description
Latest Project Brief
Value
Add a video embed url here.